What is VectorBuilder?
VectorBuilder operates as a critical infrastructure provider for the global life sciences industry, specializing in advanced gene delivery technologies. The company offers an integrated platform that streamlines the complex workflows of vector design, cloning, and viral vector manufacturing. By providing scalable solutions that bridge the gap between bench-top research and clinical-stage therapeutic development, VectorBuilder serves a diverse clientele ranging from academic laboratories to multinational pharmaceutical corporations. Their commitment to innovation is reflected in their user-centric digital platform, which simplifies the procurement and customization of genetic tools, thereby accelerating the pace of discovery in gene therapy and molecular medicine.
How much funding has VectorBuilder raised?
VectorBuilder has raised a total of $56M across 1 funding round:
Series C
$56M
Series C (2022): $56M with participation from Legend Capital
Key Investors in VectorBuilder
Legend Capital
Legend Capital is a prominent private equity firm and a member of Legend Holdings, managing significant USD and RMB funds with a focus on innovation-driven growth enterprises.
What's next for VectorBuilder?
Looking ahead, the strategic deployment of this capital will likely focus on enhancing the company's manufacturing capacity and broadening its therapeutic RNA development pipeline. As the demand for sophisticated gene delivery systems continues to surge, VectorBuilder is expected to prioritize the optimization of its automated production facilities to meet the rigorous standards of clinical applications. Furthermore, the firm is poised to deepen its market penetration by strengthening its expert support infrastructure, ensuring that its partners can navigate the complexities of gene therapy development with greater efficiency. This growth trajectory suggests a continued focus on maintaining its status as a trusted partner in the global biotech ecosystem, potentially exploring new frontiers in personalized medicine and advanced therapeutic modalities.
See full VectorBuilder company page
